b-Адреноблокаторы в терапии артериальной гипертензии: на пути к разумному компромиссу

1. Диагностика и лечение артериальной гипертензии. Российские рекомендации (4-й пересмотр). Системные гипертензии. 2010; 3: 5-26.

2. Hypertension: clinical management of primary hypertension in adults. NICE clinical guideline 127, 2011; guidance.nice.org.uk/CG 127.

3. Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27 (11): 2121-58.

4. Dahlof B et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required in the ASCOT-BPLA: a multicenter randomized controlled trial. Lancet 2005; 366: 895-906.

5. Carlberg B, Samuelsson O, Lindholm LN. Atenolol in hypertension: is it a wise choise? Lancet 2004; 364 (9446): 1684-9.

6. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366: 1545-53.

7. The CAFE Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-25.

8. Mancia G, De Baker G, Dominiczak A et al. ESH-ESC Practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the management of arterial hypertension. J Hypertens 2007; 25 (9): 1751-62.

9. Elliott W, Meyer P. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369: 201-7.

10. De Caterina AR, Leone AM. The role of beta-blockers as first-line therapy in hypertension. Curr Atheroscler Rep 2011; 13 (2): 147-53.

11. Wiysonge CS, Bradley HA, Volmink J et al. Cochrane Database Syst Rev 2012; 8: CD002003.

12. Stoschitzky K. Individual beta-blockers for individual patients. E-journal ESC Council Cardiology practice 2008; 6 (19).

13. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J 1985; 291 (6488): 97-104.

14. Прогнозирование и профилактика кардиальных осложнений внесердечных хирургических вмешательств. Национальные рекомендации. Кардиоваскулярная терапия и профилактика. 2011; Прил. 3: 10 (6).

15. Leonetti G, Egan CG. Use of carvedilol in hypertension: an update. Vasc Health Risk Manag 2012; 8: 307-22.

16. Bangalore S, Messerli FH. Beta-blockers in hypertension to use or not to use? Kardiovaskulare Medizine 2008; 11: 117-23.

17. Клинические рекомендации «Диагностика и лечение артериальной гипертензии у беременных». ВНОК-РМОАГ. 2010; http://www.ncagip.ru/news/1438.html

18. Aronow WS. Current role of beta-blockers in the treatment of hypertension. Expert Opin Pharmacother 2010; 11: 2599-607.

19. Yusuf S, Pais P, Afzal R et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009; 373 (9672): 1341-51.

20. Rothwell PM, Howard SC, Dolan E et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375 (9718): 895-905.

21. Rothwell PM. Does blood pressure variability modulate cardiovascular risk? Curr Hypertens Rep 2011; 13 (3): 177-86.

22. Кобалава Ж.Д., Гудков К.М. Метопролол CR/XL: усовершенствованная форма эталонного бета-блокатора. Кардиология. 2003; 9: 91-100.

23. Hedblad B, Wikstrand J, Janzon L. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness main result from the β-Blockers Cholesterol-lowering Asymptomatic Plaque Study (BCAPS). Circulation 2001; 103: 1721-6.

24. Wiklund O, Hulthe J, Wikstrand J. Effect of controlled releaize/extended releaize metoprolol on carotid intima-media thickness in patients with hypercholesterolemia a 3-year randomized study. Stroke 2002; 33: 572-7.

25. Shiri R, Koskimäki J, Häkkinen J et al. Cardiovascular Drug Use and the Incidence of Erectile Dysfunction. Int J Impot Res 2007; 19 (2): 208-12.